Cumberland Pharmaceuticals, Inc. (CPIX) Reports In-Line Q1 EPS
Cumberland Pharmaceuticals, Inc. (NASDAQ: CPIX) reported Q1 EPS of $0.05, in-line with the analyst estimate of $0.05. Revenue for the quarter came in at $10.3 million versus the consensus estimate of $10 million.
For earnings history and earnings-related data on Cumberland Pharmaceuticals, Inc. (CPIX) click here.
For earnings history and earnings-related data on Cumberland Pharmaceuticals, Inc. (CPIX) click here.